Learn more about ‘the silent epidemic’ of hepatitis C at a free community event March 28 at Geisinger Commonwealth School of Medicine
Do you want to know your screening and prevention options? Register today!
SCRANTON, Pa. – Many people with hepatitis C don't even know they have it. Symptoms can take decades to appear, all the while damaging the liver. That’s why hepatitis C is a dangerous — often fatal — “silent epidemic.” On Wednesday, March 28, Geisinger Commonwealth School of Medicine invites the community to learn more about hep C, its causes, prevention and screening from Michael Sulzinski, PhD, professor of immunology and microbiology.
“We’ll discuss possible signs and symptoms of a hep C infection and potential long-term complications, including liver disease and cancer,” Dr. Sulzinski said. “We’ll identify the population groups who are more at risk and explain how molecular testing is applied to anti-viral drug therapies that can cure the infection. Everyone is at risk, so it’s important for everyone to know about screening options and treatments.”
The free community event is scheduled for Thursday, March 28, from 5:30 to 7 p.m. at Geisinger Commonwealth School of Medicine, 525 Pine St., Scranton. Continuing education credits are available.
To register, visit go.geisinger.edu/communitymarch
.
About Geisinger College of Health Sciences
Geisinger College of Health Sciences is the research and education arm of the Geisinger family. Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, and the College. The College houses a Research Institute, Geisinger Commonwealth School of Medicine, Geisinger School of Nursing and the School of Graduate Education, in addition to Geisinger graduate medical education programs and its Academy of Educators. The College is committed to non-discrimination in all employment and educational opportunities. Visit geisinger.edu/gchs.
“We’ll discuss possible signs and symptoms of a hep C infection and potential long-term complications, including liver disease and cancer,” Dr. Sulzinski said. “We’ll identify the population groups who are more at risk and explain how molecular testing is applied to anti-viral drug therapies that can cure the infection. Everyone is at risk, so it’s important for everyone to know about screening options and treatments.”
The free community event is scheduled for Thursday, March 28, from 5:30 to 7 p.m. at Geisinger Commonwealth School of Medicine, 525 Pine St., Scranton. Continuing education credits are available.
To register, visit go.geisinger.edu/communitymarch
.
About Geisinger College of Health Sciences
Geisinger College of Health Sciences is the research and education arm of the Geisinger family. Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, and the College. The College houses a Research Institute, Geisinger Commonwealth School of Medicine, Geisinger School of Nursing and the School of Graduate Education, in addition to Geisinger graduate medical education programs and its Academy of Educators. The College is committed to non-discrimination in all employment and educational opportunities. Visit geisinger.edu/gchs.
For education media inquiries
Elizabeth Zygmunt
Marketing and Communications Strategist for Education
Office: 570-504-9687
On call: 570-687-9703
emzygmunt1@geisinger.edu
Content from General Links with modal content